GO:0035097 histone methyltransferase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035097 defines the histone methyltransferase complex, a multimeric cellular component that catalyzes methyl group addition to histone proteins.
• Core complexes include Polycomb repressive complex 2 (PRC2) and the WRAD (WDR5-RbBP5-ASH2L-DPY30) module that supports SET1 family enzymes.
• Histone methyltransferase complexes regulate gene expression, heterochromatin formation, and developmental programs, and their dysregulation is linked to cancer and cardiovascular disease.
• Cryo-EM has enabled high-resolution structures of histone methyltransferase complexes bound to nucleosomes, revealing substrate recognition mechanisms.
• Key catalytic subunits such as EZH2 and SUV39H1 exhibit context-dependent functions beyond the nucleus, including Golgi regulation.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential for dissecting subunit-specific roles within these complexes.
Description
The histone methyltransferase complex (GO:0035097) is a multimeric cellular component that catalyzes the addition of methyl groups to histone proteins. This post-translational modification, primarily on lysine and arginine residues of histones H3 and H4, serves as a fundamental epigenetic mark that regulates chromatin structure and gene transcription. The complex is not a single entity but a family of assemblies, each with distinct subunit compositions and substrate specificities, including the Polycomb repressive complex 2 (PRC2) and the SET1/MLL family complexes. Understanding these complexes is critical because they orchestrate developmental gene silencing, X-chromosome inactivation, and cellular differentiation. Dysregulation of histone methyltransferase activity has been implicated in numerous pathologies, from cancer to cardiovascular disorders and neuropsychiatric conditions. The structural and functional characterization of these complexes has been accelerated by advances in cryo-electron microscopy, which allows visualization of the complex bound to its nucleosome substrate. This article provides a comprehensive overview of the histone methyltransferase complex, covering its definition, composition, mechanisms, associated genes, disease relevance, and research methodologies, with a focus on how CRISPR-based models can elucidate its functions.
histone methyltransferase complex At A Glance
| GO ID | GO:0035097 |
|---|---|
| GO term | histone methyltransferase complex |
| Ontology | cellular_component |
| Synonym | None |
| Major function | Catalyzes methyl group addition to histone proteins |
| Substrate | Histone proteins (e.g., H3, H4) |
| Representative complexes | PRC2, SET1/MLL complexes, WRAD module |
| Cellular localization | Nucleus, chromatin |
| Disease relevance | Cancer, cardiovascular disease, depression, developmental disorders |
What Is GO:0035097?
According to the Gene Ontology, GO:0035097 (histone methyltransferase complex) is defined as a multimeric complex that is able to catalyze the addition of methyl groups to histone proteins. This definition emphasizes two key aspects: the complex is composed of multiple subunits (multimeric), and its enzymatic activity specifically targets histone proteins, resulting in methylation. The term is classified under the cellular_component ontology, indicating it describes a physical structure within the cell rather than a process or function. No synonyms are listed in QuickGO for this term.
Why Is histone methyltransferase complex Important in Cell Biology?
The histone methyltransferase complex is a central regulator of epigenetic gene expression, and its importance spans basic biology to clinical medicine. By depositing methyl marks on histones, these complexes control chromatin accessibility and transcriptional programs essential for development, differentiation, and homeostasis. Mutations or dysregulation of complex subunits are frequently observed in human diseases, including various cancers, cardiovascular disorders, and neuropsychiatric conditions. Moreover, the complex is a target for therapeutic intervention, with inhibitors of EZH2 already in clinical trials for cancer. Understanding the structure, assembly, and regulation of these complexes is therefore critical for both fundamental research and drug discovery.
• Regulates gene expression through histone methylation, influencing cell fate decisions.
• Essential for developmental processes such as embryogenesis and hematopoiesis.
• Dysregulation is linked to cancer, including lymphomas and solid tumors.
• Implicated in cardiovascular disease pathogenesis via epigenetic mechanisms.
• Plays a role in neuropsychiatric disorders such as depression through microglial polarization.
• SUV39H1, a histone methyltransferase, regulates Golgi complex via LINC complex.
• WRAD complex is critical for SET1 family methyltransferase functions.
• EZH2 complex exhibits substrate preferences that determine methylation specificity.
• Cryo-EM provides structural insights into nucleosome recognition by these complexes.
• CRISPR screening can identify novel subunits and modulators of the complex.
What Happens During histone methyltransferase complex?
Assembly of the Multimeric Complex
In simple terms: The complex is built from several protein subunits that come together to form a functional machine.
Histone methyltransferase complexes are assembled from multiple subunits, each contributing to structural integrity, substrate recognition, or catalytic activity. For example, the WRAD complex (WDR5, RbBP5, ASH2L, and DPY30) serves as a core module that associates with SET1 family methyltransferases to form active holoenzymes. Similarly, PRC2 comprises EZH2 (catalytic subunit), SUZ12, EED, and RbAp48, which are essential for its methyltransferase activity. Assembly is often regulated by cellular signals and developmental cues, ensuring proper complex formation at the right time and place.
Substrate Recognition and Binding
In simple terms: The complex finds and attaches to specific histone proteins on the nucleosome.
The histone methyltransferase complex recognizes specific histone tails, often through accessory subunits that bind to post-translational modifications or DNA. For instance, the EZH2 complex exhibits substrate preferences for histone H3 lysine 27 (H3K27), and its activity is influenced by the nucleosome context. Structural studies using cryo-EM have revealed how the complex engages the nucleosome, with the catalytic domain positioned near the target lysine residue. This recognition is highly specific and ensures that methylation occurs at the correct genomic loci.
Catalysis of Methyl Group Transfer
In simple terms: The complex transfers a methyl group from a donor molecule to a histone protein.
The catalytic step involves the transfer of a methyl group from S-adenosylmethionine (SAM) to a lysine or arginine residue on the histone substrate. This reaction is mediated by the SET domain, a conserved catalytic domain found in most histone lysine methyltransferases. The WRAD complex enhances the catalytic efficiency of SET1 family enzymes, possibly by stabilizing the active conformation. The methylation reaction can occur in successive rounds, leading to mono-, di-, or trimethylation, which have distinct functional consequences.
Chromatin Modification and Downstream Effects
In simple terms: The methyl marks added by the complex change how DNA is packaged, affecting gene activity.
Once deposited, methyl marks on histones serve as docking sites for reader proteins that interpret the epigenetic code. For example, H3K27 methylation by PRC2 leads to transcriptional repression through the recruitment of Polycomb group proteins. In contrast, H3K4 methylation by SET1 family complexes is associated with active transcription. These downstream effects influence diverse processes, including cell proliferation, differentiation, and responses to environmental signals.
Key Genes Involved in GO:0035097 histone methyltransferase complex
The following genes encode subunits or regulators of the histone methyltransferase complex, each with distinct roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EZH2 | Catalytic subunit of PRC2, methylates H3K27 | Target in cancer, cardiovascular disease, and depression models |
| SUZ12 | Essential subunit of PRC2 | Required for PRC2 stability and activity |
| EED | Subunit of PRC2, binds methylated histones | Allosteric activation of PRC2 |
| RbAp48 | Subunit of PRC2, histone chaperone | Facilitates nucleosome binding |
| WDR5 | Core subunit of WRAD complex | Scaffold for SET1 family complexes |
| RbBP5 | Core subunit of WRAD complex | Enhances methyltransferase activity |
| ASH2L | Core subunit of WRAD complex | Stimulates SET1-mediated methylation |
| DPY30 | Core subunit of WRAD complex | Modulates complex assembly and activity |
| SETD1A | Catalytic subunit of SET1 complex | Methylates H3K4, linked to leukemia |
| MLL1 | Catalytic subunit of MLL complex | Frequently rearranged in leukemia |
| SUV39H1 | Methylates H3K9, heterochromatin formation | Regulates Golgi complex via LINC complex |
| LaeA | Putative histone methyltransferase in fungi | Regulates cellulolytic gene expression |
| ClrB | Transcription factor bridging Tup1-Cyc8 and LaeA | Activates cellulolytic genes |
| Tup1 | Corepressor in Tup1-Cyc8 complex | Bridges ClrB and LaeA |
| Cyc8 | Corepressor in Tup1-Cyc8 complex | Bridges ClrB and LaeA |
| PRC2 | Polycomb repressive complex 2 | Silences developmental genes |
| WRAD | WDR5-RbBP5-ASH2L-DPY30 complex | Essential for SET1 family functions |
How Is histone methyltransferase complex Regulated?
The activity of histone methyltransferase complexes is tightly regulated at multiple levels. Post-translational modifications of subunits, such as phosphorylation and ubiquitination, can modulate complex assembly and catalytic activity. Interaction with non-coding RNAs and transcription factors can recruit complexes to specific genomic loci. In addition, metabolic availability of the methyl donor S-adenosylmethionine (SAM) influences methylation capacity. Dysregulation of these regulatory mechanisms can lead to aberrant methylation patterns associated with disease.
histone methyltransferase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Cancer, depression | Knockout or point mutation in cancer cell lines; overexpression in microglia |
| MLL1 | Leukemia | Knock-in of fusion alleles in hematopoietic stem cells |
| SUV39H1 | Golgi regulation | Knockout in HeLa cells followed by imaging |
| LaeA | Fungal cellulolytic gene expression | Knockout in Aspergillus nidulans |
| WRAD components | Developmental disorders | Knockout in embryonic stem cells |
Histone Methyltransferase Complex in Cancer
Dysregulation of histone methyltransferase complexes is a hallmark of many cancers. EZH2, the catalytic subunit of PRC2, is overexpressed in lymphomas and solid tumors, where it promotes aberrant gene silencing that drives proliferation and survival. Mutations in MLL1, a SET1 family methyltransferase, are common in acute leukemias, leading to fusion proteins with altered methylation activity. Targeting these complexes with small molecule inhibitors, such as EZH2 inhibitors, has shown promise in clinical trials.
Cardiovascular Disease
Epigenetic regulation by histone methyltransferases contributes to cardiovascular pathology. Altered expression of EZH2 and other complex subunits has been observed in heart failure and atherosclerosis, influencing smooth muscle cell phenotype and inflammation. Modulating these complexes may offer therapeutic avenues for cardiovascular disease.
Neuropsychiatric Disorders
Emerging evidence links histone methyltransferase complexes to neuropsychiatric conditions. In a rat model of depression, EZH2 was found to exacerbate inflammation by modulating microglia polarization, suggesting a role for PRC2 in neuroinflammation. This highlights the complex's involvement beyond traditional epigenetic roles.
Golgi Regulation and Beyond
SUV39H1, a histone methyltransferase, has been shown to regulate the Golgi complex via the nuclear envelope-spanning LINC complex, revealing non-nuclear functions. This expands the scope of histone methyltransferase biology and suggests potential roles in organelle dynamics and cellular stress responses.
From histone methyltransferase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic role of EZH2 in cancer? | EZH2 knockout or point mutation in cancer cell lines |
| How does SUV39H1 regulate Golgi structure? | SUV39H1 knockout in HeLa cells with LINC complex imaging |
| What is the function of WRAD in SET1 complex? | Knockout of WDR5, RbBP5, ASH2L, or DPY30 in HEK293T cells |
| How does LaeA regulate cellulolytic genes? | LaeA knockout in Aspergillus nidulans |
| What is the effect of EZH2 overexpression in depression? | EZH2 overexpression in rat microglia |
| How does MLL1 fusion drive leukemia? | Knock-in of MLL-AF9 fusion in mouse hematopoietic cells |
How to Study the histone methyltransferase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of complex-nucleosome | Visualizing subunit arrangement and substrate binding |
| Methyltransferase assay | Catalytic activity and substrate specificity | Testing EZH2 mutants |
| ChIP-seq | Genomic localization of histone marks | Mapping H3K27me3 across the genome |
| RNA-seq | Transcriptional changes | Assessing effects of EZH2 knockout |
| Mass spectrometry | Methylation sites and stoichiometry | Identifying novel histone substrates |
| CRISPR knockout | Gene function loss | Studying subunit essentiality |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking complex localization |
| Co-immunoprecipitation | Protein-protein interactions | Defining complex composition |
Structural Biology (Cryo-EM)
Cryo-electron microscopy (cryo-EM) is a powerful method to determine the structures of histone methyltransferase complexes in complex with nucleosomes. This technique has been used to visualize the catalytic domain of EZH2 bound to its substrate, revealing key interactions. Cryo-EM allows researchers to understand how subunits coordinate substrate recognition and catalysis at near-atomic resolution.
Biochemical Assays
In vitro methyltransferase assays using recombinant complexes and histone substrates are standard for measuring catalytic activity. These assays can determine substrate specificity, kinetic parameters, and the effect of mutations. They are often complemented by mass spectrometry to identify methylation sites.
Genomic and Epigenomic Profiling
Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is used to map the genomic localization of histone methyltransferase complexes and their associated histone marks, such as H3K27me3 or H3K4me3. RNA-seq can reveal transcriptional changes upon complex perturbation.
CRISPR-Based Functional Genomics
CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of histone methyltransferase complex subunits in cellular contexts. For example, knockout of EZH2 can abolish H3K27 methylation and alter gene expression. These models are essential for linking specific subunits to disease phenotypes.
How CRISPR Can Be Used to Study GO:0035097 histone methyltransferase complex
Knockout
CRISPR knockout is used to completely ablate the expression of a histone methyltransferase complex subunit, allowing researchers to assess its necessity for complex assembly and function. For example, knockout of EZH2 in cancer cell lines leads to loss of H3K27 methylation and reactivation of silenced genes. Knockout of WRAD components disrupts SET1 family methyltransferase activity.
Point Mutation
Point mutations can be introduced into catalytic residues or interaction domains to dissect specific functions without affecting protein stability. For instance, mutation of the SET domain of EZH2 can abolish methyltransferase activity while preserving complex formation. Such models are valuable for separating catalytic from scaffolding roles.
Knock-in
Knock-in of tagged or fluorescently labeled subunits enables live-cell imaging and proteomic studies. For example, knock-in of GFP-tagged SUV39H1 allows tracking of its localization to the Golgi complex. Knock-in of disease-associated mutations can model their effects on complex function.
Overexpression
Overexpression of wild-type or mutant subunits can mimic disease states where the complex is upregulated. Overexpression of EZH2 in microglia exacerbates inflammation in depression models. This approach is useful for gain-of-function studies and drug screening.
How EDITGENE Supports histone methyltransferase complex Research
Researchers studying histone methyltransferase complex-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based models. EDITGENE provides a comprehensive suite of services to support such investigations, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for histone methyltransferase complex research.
Frequently Asked Questions About histone methyltransferase complex
What is GO:0035097?
GO:0035097 is the Gene Ontology term for histone methyltransferase complex, a multimeric cellular component that catalyzes methyl group addition to histone proteins.
What genes are involved in histone methyltransferase complex?
Key genes include EZH2, SUZ12, EED, RbAp48 (PRC2 subunits), and WDR5, RbBP5, ASH2L, DPY30 (WRAD subunits), as well as SET1 family members like MLL1.
What is the function of histone methyltransferase complex?
It adds methyl groups to histone proteins, thereby regulating chromatin structure and gene expression.
How is histone methyltransferase complex regulated?
It is regulated by post-translational modifications, interaction with non-coding RNAs, and availability of the methyl donor SAM.
What diseases are associated with histone methyltransferase complex?
Dysregulation is linked to cancer, cardiovascular disease, depression, and developmental disorders.
What methods are used to study histone methyltransferase complex?
Cryo-EM, methyltransferase assays, ChIP-seq, RNA-seq, and CRISPR-based models are commonly used.
What is the role of EZH2 in histone methyltransferase complex?
EZH2 is the catalytic subunit of PRC2, methylating H3K27 to repress gene expression.
How does SUV39H1 regulate the Golgi complex?
SUV39H1 regulates the Golgi via the nuclear envelope-spanning LINC complex, revealing non-nuclear functions.
What is the WRAD complex?
WRAD (WDR5-RbBP5-ASH2L-DPY30) is a core module that associates with SET1 family methyltransferases to form active complexes.
Can CRISPR be used to study histone methyltransferase complex?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect subunit functions.
Conclusion
The histone methyltransferase complex (GO:0035097) is a critical epigenetic regulator that controls gene expression through histone methylation. Its diverse subunit compositions and substrate specificities enable precise regulation of developmental and homeostatic programs, and its dysregulation contributes to cancer, cardiovascular disease, and neuropsychiatric disorders. Advances in structural biology and CRISPR-based functional genomics continue to illuminate the mechanisms of these complexes, offering new opportunities for therapeutic intervention. Researchers can leverage EDITGENE's comprehensive CRISPR services to accelerate discoveries in this field.
References
- 1. Spangler CJ et al.. 2022. Determination of Histone Methyltransferase Structures in Complex with the Nucleosome by Cryogenic Electron Microscopy.. Methods Mol Biol 2529:149-168 PMID: 35733015
- 2. Nishino M et al.. 2023. Histone methyltransferase SUV39H1 regulates the Golgi complex via the nuclear envelope-spanning LINC complex.. PLoS One 18(7):e0283490 PMID: 37437070
- 3. Shi Y et al.. 2022. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.. Signal Transduct Target Ther 7(1):200 PMID: 35752619
- 4. Cao R et al.. 2002. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.. Science 298(5595):1039-43 PMID: 12351676
- 5. Ali A et al.. 2017. Diverse roles of WDR5-RbBP5-ASH2L-DPY30 (WRAD) complex in the functions of the SET1 histone methyltransferase family.. J Biosci 42(1):155-159 PMID: 28229975
- 6. Huang X et al.. 2022. Histone methyltransferase enhancer of zeste 2 polycomb repressive complex 2 subunit exacerbates inflammation in depression rats by modulating microglia polarization.. Bioengineered 13(3):5509-5524 PMID: 35172677
- 7. Zhang X et al.. 2022. The complex Tup1-Cyc8 bridges transcription factor ClrB and putative histone methyltransferase LaeA to activate the expression of cellulolytic genes.. Mol Microbiol 117(5):1002-1022 PMID: 35072962
- 8. Martin C et al.. 2006. Substrate preferences of the EZH2 histone methyltransferase complex.. J Biol Chem 281(13):8365-70 PMID: 16431907
